JP2002508334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002508334A5 JP2002508334A5 JP2000538716A JP2000538716A JP2002508334A5 JP 2002508334 A5 JP2002508334 A5 JP 2002508334A5 JP 2000538716 A JP2000538716 A JP 2000538716A JP 2000538716 A JP2000538716 A JP 2000538716A JP 2002508334 A5 JP2002508334 A5 JP 2002508334A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- microparticles
- poly
- selected antigen
- lactide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 description 34
- 239000000427 antigen Substances 0.000 description 26
- 102000036639 antigens Human genes 0.000 description 26
- 108091007433 antigens Proteins 0.000 description 26
- 239000011859 microparticle Substances 0.000 description 25
- 239000007764 o/w emulsion Substances 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 5
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 3
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 3
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920001432 poly(L-lactide) Polymers 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 229940031439 squalene Drugs 0.000 description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 3
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6972497P | 1997-12-16 | 1997-12-16 | |
| US60/069,724 | 1997-12-16 | ||
| PCT/US1998/001656 WO1999030737A1 (en) | 1997-12-16 | 1998-01-29 | Use of microparticles combined with submicron oil-in-water emulsions |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007292637A Division JP2008050374A (ja) | 1997-12-16 | 2007-11-09 | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 |
| JP2011250804A Division JP2012036223A (ja) | 1997-12-16 | 2011-11-16 | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002508334A JP2002508334A (ja) | 2002-03-19 |
| JP2002508334A5 true JP2002508334A5 (cg-RX-API-DMAC7.html) | 2012-01-26 |
| JP4918188B2 JP4918188B2 (ja) | 2012-04-18 |
Family
ID=22090819
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000538716A Expired - Fee Related JP4918188B2 (ja) | 1997-12-16 | 1998-01-29 | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 |
| JP2007292637A Withdrawn JP2008050374A (ja) | 1997-12-16 | 2007-11-09 | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 |
| JP2011250804A Withdrawn JP2012036223A (ja) | 1997-12-16 | 2011-11-16 | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007292637A Withdrawn JP2008050374A (ja) | 1997-12-16 | 2007-11-09 | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 |
| JP2011250804A Withdrawn JP2012036223A (ja) | 1997-12-16 | 2011-11-16 | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US6086901A (cg-RX-API-DMAC7.html) |
| EP (1) | EP1042001B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP4918188B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE215385T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU6253898A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2314934C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69804671T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1042001T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2175668T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1042001E (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999030737A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990014837A1 (en) * | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| CA2156718A1 (en) | 1993-12-23 | 1995-06-29 | Bruno Gander | Immunological response potentiation process |
| EP2298900A1 (en) * | 1996-09-17 | 2011-03-23 | Novartis Vaccines and Diagnostics, Inc. | Compositions and methods for treating intracellular diseases |
| ES2195317T3 (es) * | 1997-01-30 | 2003-12-01 | Chiron Corp | Uso de microparticulas con antigeno adsorbido para estimular respuestas inmunitarias. |
| US20040202680A1 (en) * | 1997-01-30 | 2004-10-14 | O'hagan Derek | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| US6884435B1 (en) | 1997-01-30 | 2005-04-26 | Chiron Corporation | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| PT1042001E (pt) * | 1997-12-16 | 2002-09-30 | Chiron Corp | Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua |
| US7393630B2 (en) * | 1997-12-16 | 2008-07-01 | Novartis Vaccines And Diagnostics, Inc. | Use of microparticles combined with submicron oil-in-water emulsions |
| WO2000050006A2 (en) * | 1999-02-26 | 2000-08-31 | Chiron Corporation | Microemulsions with adsorbed macromoelecules and microparticles |
| AU2457100A (en) * | 1999-02-26 | 2000-09-14 | Chiron S.P.A. | Enhancement of bactericidal activity of neisseria antigens with oligonucleotidescontaining cg motifs |
| ATE454901T1 (de) * | 1999-10-13 | 2010-01-15 | Novartis Vaccines & Diagnostic | Verfahren zur erhaltung zellimmuneantworten gegen proteinen |
| CA2389613A1 (en) * | 1999-11-19 | 2001-05-25 | Zycos Inc. | Continuous-flow method for preparing microparticles |
| US7329408B2 (en) * | 1999-12-01 | 2008-02-12 | Novartis Vaccines And Diagnostics, Inc. | Eliciting HCV-specific antibodies |
| US20030129251A1 (en) | 2000-03-10 | 2003-07-10 | Gary Van Nest | Biodegradable immunomodulatory formulations and methods for use thereof |
| US7129222B2 (en) * | 2000-03-10 | 2006-10-31 | Dynavax Technologies Corporation | Immunomodulatory formulations and methods for use thereof |
| US20040022814A1 (en) * | 2000-06-15 | 2004-02-05 | O'hagan Derek | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| US20030138769A1 (en) * | 2000-08-16 | 2003-07-24 | Birkett Ashley J. | Immunogenic HBc chimer particles having enhanced stability |
| US20030138453A1 (en) * | 2000-09-28 | 2003-07-24 | O'hagan Derek | Microparticles for delivery of heterologous nucleic acids |
| WO2002026212A2 (en) | 2000-09-28 | 2002-04-04 | Chiron Corporation | Microparticle compositions and methods for the manufacture thereof |
| ES2399386T3 (es) * | 2001-04-05 | 2013-04-01 | Novartis Vaccines And Diagnostics, Inc. | Aumento de la inmunidad de las mucosas tras sensibilización parenteral |
| US8481043B2 (en) * | 2001-06-22 | 2013-07-09 | Cpex Pharmaceuticals, Inc. | Nasal immunization |
| AU2002322358B2 (en) * | 2001-06-29 | 2009-06-18 | Novartis Vaccines And Diagnostics, Inc. | HCV E1E2 vaccine compositions |
| US7361352B2 (en) | 2001-08-15 | 2008-04-22 | Acambis, Inc. | Influenza immunogen and vaccine |
| US20030185858A1 (en) * | 2001-08-15 | 2003-10-02 | Birkett Ashley J. | Immunogenic HBc chimer particles stabilized with an N-terminal cysteine |
| US20030175863A1 (en) * | 2001-08-15 | 2003-09-18 | Birkett Ashley J. | Influenza immunogen and vaccine |
| AR045702A1 (es) * | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
| WO2003055323A1 (en) * | 2001-12-27 | 2003-07-10 | Genesis Group Inc. | Seal oil based lipid emulsions and uses thereof |
| ES2339762T3 (es) * | 2002-01-14 | 2010-05-25 | Novartis Vaccines And Diagnostics, Inc. | Vacuna contra el vih y procedimiento de uso. |
| US7351413B2 (en) * | 2002-02-21 | 2008-04-01 | Lorantis, Limited | Stabilized HBc chimer particles as immunogens for chronic hepatitis |
| US6861410B1 (en) * | 2002-03-21 | 2005-03-01 | Chiron Corporation | Immunological adjuvant compositions |
| US7056901B2 (en) * | 2002-03-29 | 2006-06-06 | The Regents Of The University Of California | Microgel particles for the delivery of bioactive materials |
| RU2214278C1 (ru) * | 2002-05-27 | 2003-10-20 | Закрытое Акционерное Общество "Нита-Фарм" | Адьювант для биопрепаратов |
| US20040013688A1 (en) * | 2002-07-03 | 2004-01-22 | Cambridge Scientific, Inc. | Vaccines to induce mucosal immunity |
| AU2003254792A1 (en) * | 2002-08-02 | 2004-02-23 | Sumitomo Pharmaceuticals Company, Limited | Bacterial cell wall skeleton component preparaion |
| US7884083B2 (en) * | 2002-08-12 | 2011-02-08 | Dynavax Technologies Corporation | Immunomodulatory compositions, methods of making, and methods of use thereof |
| WO2004032860A2 (en) * | 2002-10-07 | 2004-04-22 | Chiron Corporation | Hiv vaccine formulations |
| US7955260B2 (en) * | 2002-10-18 | 2011-06-07 | Datacquire, Inc. | Method for rating severity of psoriasis |
| EP2263687B1 (en) * | 2002-12-27 | 2015-03-25 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic compositions containing phospholipid |
| US20050191358A1 (en) * | 2003-01-14 | 2005-09-01 | Derek O' Hagan | Microparticles with adsorbed polynucleotide-containing species |
| RU2541809C2 (ru) * | 2003-04-04 | 2015-02-20 | Зоетис Пи ЛЛК | Микрофлюидизированные эмульсии "масло в воде" и композиции вакцины |
| WO2004091491A2 (en) * | 2003-04-10 | 2004-10-28 | Transform Pharmaceuticals, Inc. | Profiling conformational variants, antibody compositions and methods of using the same |
| WO2005003180A2 (en) * | 2003-04-10 | 2005-01-13 | Pr Pharmaceuticals | A method for the production of emulsion-based micro particles |
| US20070207211A1 (en) * | 2003-04-10 | 2007-09-06 | Pr Pharmaceuticals, Inc. | Emulsion-based microparticles and methods for the production thereof |
| WO2004096136A2 (en) * | 2003-04-25 | 2004-11-11 | Chiron Corporation | Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| ES2596553T3 (es) | 2003-06-02 | 2017-01-10 | Glaxosmithkline Biologicals Sa | Composiciones inmunogénicas a base de micropartículas que comprenden toxoide adsorbido y un antígeno que contiene un polisacárido |
| US7208395B2 (en) * | 2003-06-26 | 2007-04-24 | Semiconductor Energy Laboratory Co., Ltd. | Laser irradiation apparatus, laser irradiation method, and method for manufacturing semiconductor device |
| US20050053667A1 (en) * | 2003-07-09 | 2005-03-10 | Darrell Irvine | Programmed immune responses using a vaccination node |
| AU2004259208B2 (en) * | 2003-07-15 | 2011-04-28 | Evonik Corporation | Method for the preparation of controlled release formulations |
| AU2004259209A1 (en) * | 2003-07-23 | 2005-02-03 | Pr Pharmaceuticals, Inc. | Controlled release compositions |
| CA2564180A1 (en) * | 2004-04-22 | 2005-11-03 | Dainippon Sumitomo Pharma Co., Ltd. | Pharmaceutical preparation containing bacterial cell wall skeleton component |
| FR2873386B1 (fr) | 2004-07-22 | 2011-01-14 | Agence Francaise De Securite Sanitaire Des Aliments Afssa | Composition vaccinale contre le rhodococcus equi |
| AU2005334819B2 (en) * | 2004-11-15 | 2011-11-24 | Novartis Vaccines And Diagnostics Inc. | Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant |
| MX2009004866A (es) * | 2006-11-03 | 2009-05-19 | Schering Plough Ltd | Vacuna para enfermedad de lyme canina. |
| CL2008001806A1 (es) | 2007-06-20 | 2008-09-05 | Wyeth Corp | Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion. |
| WO2009016639A2 (en) | 2007-08-02 | 2009-02-05 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope influenza vaccines |
| ES2588705T3 (es) * | 2007-09-27 | 2016-11-04 | Immunovaccine Technologies Inc. | Uso de liposomas en un vehículo que comprende una fase hidrófoba continua para la entrega de polinucleótidos in vivo |
| US20100209452A1 (en) * | 2007-10-03 | 2010-08-19 | Immunovaccine Technologies, Inc | Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
| AU2008331800A1 (en) | 2007-12-03 | 2009-06-11 | President And Fellows Of Harvard College | Chlamydia antigens |
| AU2008335457B2 (en) * | 2007-12-07 | 2015-04-16 | Glaxosmithkline Biologicals S.A. | Compositions for inducing immune responses |
| US20110151015A1 (en) * | 2008-03-04 | 2011-06-23 | Liquikia Technologies, Inc. | Immunomodulator particles and methods of treating |
| CA2723918C (en) | 2008-06-05 | 2018-01-09 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| NZ591768A (en) * | 2008-09-18 | 2012-11-30 | Novartis Ag | Vaccine adjuvant combinations |
| JP2012510289A (ja) | 2008-12-03 | 2012-05-10 | プロティア ワクチン テクノロジーズ リミテッド | グルタミルtRNA合成酵素(GtS)フラグメント |
| WO2011067758A2 (en) | 2009-12-02 | 2011-06-09 | Protea Vaccine Technologies Ltd. | Immunogenic fragments and multimers from streptococcus pneumoniae proteins |
| WO2011119920A2 (en) | 2010-03-25 | 2011-09-29 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| US20110293690A1 (en) * | 2010-05-27 | 2011-12-01 | Tyco Healthcare Group Lp | Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof |
| CA2804591C (en) | 2010-07-06 | 2019-01-22 | Novartis Ag | Cationic oil-in-water emulsions |
| WO2012114323A1 (en) | 2011-02-22 | 2012-08-30 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| ES2667425T3 (es) | 2011-06-10 | 2018-05-10 | Oregon Health & Science University | Glucoproteínas y vectores recombinantes de CMV |
| US20130004640A1 (en) * | 2011-07-01 | 2013-01-03 | Pepsico, Inc. | Complex coacervates, methods and food products |
| US9655845B2 (en) | 2011-07-06 | 2017-05-23 | Glaxosmithkline Biologicals, S.A. | Oil-in-water emulsions that contain nucleic acids |
| US9636410B2 (en) | 2011-07-06 | 2017-05-02 | Glaxosmithkline Biologicals Sa | Cationic oil-in-water emulsions |
| AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
| IN2014CN02581A (cg-RX-API-DMAC7.html) | 2011-10-06 | 2015-08-07 | Immunovaccine Technologies Inc | |
| EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
| ES2702278T3 (es) | 2012-04-01 | 2019-02-28 | Technion Res & Dev Foundation | Péptidos de inductor de metaloproteinasa de matriz extracelular (emmprin) y anticuerpos de unión |
| EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
| US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
| EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| US10426828B2 (en) | 2014-04-03 | 2019-10-01 | Biondvax Pharmaceuticals Ltd. | Compositions of multimeric-multiepitope influenza polypeptides and their production |
| US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| WO1990014837A1 (en) * | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| WO1992000081A1 (en) * | 1990-06-29 | 1992-01-09 | Chiron Corporation | Vaccine compositions containing liposomes |
| US5928865A (en) * | 1992-03-02 | 1999-07-27 | Chiron S.P.A. | Compositions comprising isolated Helicobacter pylori CagI polynucleotides and method of preparation thereof |
| EP0724432B1 (en) * | 1993-10-22 | 2002-09-18 | Genentech, Inc. | Methods and compositions for microencapsulation of antigens for use as vaccines |
| US5961970A (en) * | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
| US5629167A (en) * | 1994-04-19 | 1997-05-13 | Biocine S.P.A. | Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| WO1995033835A1 (en) * | 1994-06-02 | 1995-12-14 | Chiron Corporation | Nucleic acid immunization using a virus-based infection/transfection system |
| GB9412273D0 (en) * | 1994-06-18 | 1994-08-10 | Univ Nottingham | Administration means |
| SK165197A3 (en) * | 1995-06-07 | 1999-01-11 | Astra Ab | Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
| GB9514285D0 (en) * | 1995-07-13 | 1995-09-13 | Univ Nottingham | Polymeric lamellar substrate particles for drug delivery |
| GB9518864D0 (en) * | 1995-09-14 | 1995-11-15 | Cambridge Res & Innovation | Oligonucleotides and their uses |
| GB9603314D0 (en) * | 1996-02-16 | 1996-04-17 | Biocine Spa | Immunogenic detoxified mutant toxins |
| US5783567A (en) * | 1997-01-22 | 1998-07-21 | Pangaea Pharmaceuticals, Inc. | Microparticles for delivery of nucleic acid |
| PT1042001E (pt) * | 1997-12-16 | 2002-09-30 | Chiron Corp | Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua |
-
1998
- 1998-01-29 PT PT98904739T patent/PT1042001E/pt unknown
- 1998-01-29 WO PCT/US1998/001656 patent/WO1999030737A1/en not_active Ceased
- 1998-01-29 JP JP2000538716A patent/JP4918188B2/ja not_active Expired - Fee Related
- 1998-01-29 CA CA002314934A patent/CA2314934C/en not_active Expired - Fee Related
- 1998-01-29 US US09/015,736 patent/US6086901A/en not_active Expired - Lifetime
- 1998-01-29 AU AU62538/98A patent/AU6253898A/en not_active Abandoned
- 1998-01-29 ES ES98904739T patent/ES2175668T3/es not_active Expired - Lifetime
- 1998-01-29 DK DK98904739T patent/DK1042001T3/da active
- 1998-01-29 DE DE69804671T patent/DE69804671T2/de not_active Expired - Lifetime
- 1998-01-29 AT AT98904739T patent/ATE215385T1/de active
- 1998-01-29 EP EP98904739A patent/EP1042001B1/en not_active Expired - Lifetime
-
2000
- 2000-05-02 US US09/564,416 patent/US6306405B1/en not_active Expired - Lifetime
-
2001
- 2001-08-20 US US09/935,466 patent/US6458370B1/en not_active Expired - Lifetime
-
2002
- 2002-08-02 US US10/211,025 patent/US6855492B2/en not_active Expired - Lifetime
-
2007
- 2007-11-09 JP JP2007292637A patent/JP2008050374A/ja not_active Withdrawn
-
2011
- 2011-11-16 JP JP2011250804A patent/JP2012036223A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhou et al. | Poly-d, l-lactide–co-poly (ethylene glycol) microspheres as potential vaccine delivery systems | |
| Esparza et al. | Parameters affecting the immunogenicity of microencapsulated tetanus toxoid | |
| JP2003511420A5 (cg-RX-API-DMAC7.html) | ||
| Singh et al. | Nanoparticles and microparticles as vaccine-delivery systems | |
| JP4918188B2 (ja) | サブミクロンの水中油型エマルジョンと合わせた微粒子の使用 | |
| US6287604B1 (en) | Biodegradable targetable microparticle delivery system | |
| JP2963540B2 (ja) | 薬剤移送用ポリマーミクロ粒子 | |
| AU2001294898B2 (en) | Microparticle compositions and methods for the manufacture thereof | |
| Singh et al. | Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice | |
| Singh et al. | Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine | |
| Lima et al. | Poly-DL-lactide-co-glycolide microspheres as a controlled release antigen delivery system | |
| Lavelle et al. | The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol | |
| JP2001511148A (ja) | 免疫応答を刺激するための吸着された抗原を有するマイクロパーティクルの使用 | |
| JP2004509914A5 (cg-RX-API-DMAC7.html) | ||
| Singh et al. | A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2 | |
| JP2002521425A5 (cg-RX-API-DMAC7.html) | ||
| JP2016117774A (ja) | リン脂質を含む免疫原性組成物 | |
| Vela Ramirez et al. | Polyanhydride nanovaccines induce germinal center B cell formation and sustained serum antibody responses | |
| JP2007308500A (ja) | Gm−csfの放出の延長 | |
| JP2006520746A5 (cg-RX-API-DMAC7.html) | ||
| Singh et al. | Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models | |
| Khang et al. | Preparation and characterization of Japanese encephalitis virus vaccine loaded poly (L‐lactide‐co‐glycolide) microspheres for oral immunization | |
| Johansen et al. | Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs | |
| JPH08507088A (ja) | 免疫応答の増強方法 | |
| McGee et al. | The immunogenicity of a model protein entrapped in poly (lactide-co-glycolide) microparticles prepared by a novel phase separation technique |